MediciNova Announces Presentation of Results from the Phase 2b Trial of MN-166 (ibudilast) in Alcohol Use Disorder at the 46th Annual Research Society on Alcohol (RSA) Scientific Meeting
LA JOLLA, Calif., June 29, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
OrbusNeich Expands European Footprint via Acquisition of Italian Distributor
Changzhou Microintelligence Global Offering, Maximum Offer Price HK$21.46 per Share
Lutian Global Energy Partner Conference 2026 Successfully Held, Comprehensive Solar-plus-Storage Solutions Unveiled
SAPPE Showcases Product Innovations at SIAL Paris 2026
Safety Training Seminars Opens New CPR Certification Training School in Carmel and Monterey, CA